	普通株資本		日付
Akebia Therapeutics	USD 265.42M	199K	2025-12
Alaunos Therapeutics	USD 2.21M	131K	2025-09
Clinuvel Pharmaceuticals	AUD 50.2M	77.11K	2025-12
Dianthus Therapeutics	USD 43.22M	368.53K	2025-12
Genetic Signatures	AUD 227.14M	0	2025-12
Ionis Pharmaceuticals	USD 161.97M	836K	2025-12
Medical Developments International	AUD 112.66M	2.35M	2025-12
Neuren Pharmaceuticals	AUD 126.64M	38.63M	2025-12
Organon & Co	USD 259.98M	18K	2025-09
Paradigm Biopharmaceuticals	AUD 428.52M	39.09M	2025-12
PYC Therapeutics	AUD 597.24M	366.66M	2025-12
Starpharma Holdings	AUD 419.92M	179.17M	2025-12
Tectonic Therapeutic	USD 18.74M	25.03K	2025-12
Telix Pharmaceuticals	AUD 338.78M	379K	2025-12
Viatris	USD 1.16B	6.55M	2025-09
Xeris Pharmaceuticals	USD 166.22M	687.16K	2025-12